35 (PB023): A Multicenter, Open-label Phase 1/2 Study of TYRA 300 in Advanced Urothelial Carcinoma and Other Solid Tumors with Activating FGFR3 Gene Alterations (SURF301)
Titel:
35 (PB023): A Multicenter, Open-label Phase 1/2 Study of TYRA 300 in Advanced Urothelial Carcinoma and Other Solid Tumors with Activating FGFR3 Gene Alterations (SURF301)
Auteur:
Zhang, A. Boni, V. Hanson, A. Mantia, C. Weickhardt, A. Yu, E. Gupta, S. Robert, M. Iyer, G. Millward, M. Morales-Barrera, R. Hoimes, C. Berlin, J. Mittal, K. Hill, A. Racca, F. Pouessel, D. Lihou, C. Tran, B. Loriot, Y.